NavonTech

Company Overview

Snapshot

Founded in December 2017 by Shai Feinsod, Shy Hefetz, and Yaniv Shtalryd, NavonTech operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing its core technology.

Business overview

NavonTech, operating within the Health Tech & Life Sciences sector, develops the GlycemiaCare watch, a wrist-wearable, web-connected technology designed for diabetes monitoring. This device tracks multiple physiological parameters to provide early warnings for nocturnal hypoglycemia. The GlycemiaCare watch monitors heart rate, breathing rate, skin humidity, skin temperature, muscle twitches, and skin conductivity. It serves the digital healthcare market, offering solutions for remote monitoring, and targets both B2B2C and B2B business models globally.

Company Intelligence Q&A

What is NavonTech's primary product?

NavonTech's primary product is the GlycemiaCare watch, a wrist-wearable device designed for monitoring multiple physiological parameters to provide early warnings for nocturnal hypoglycemia.

When was NavonTech founded?

NavonTech was founded in December 2017.

Who are the founders of NavonTech?

NavonTech was founded by Shai Feinsod, Shy Hefetz, and Yaniv Shtalryd.

What is the current status of NavonTech?

NavonTech is currently non-active and ceased to operate in July 2022.

What markets does NavonTech target?

NavonTech targets global markets with its digital healthcare solutions, serving both B2B2C and B2B business models.